Physician profile
Crystal Boyd
NPI 1598420267
$1,968.10
in general payments reported to CMS, 2019-2025
16 companies · $798 in 2025
The $798 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.88 · 2022: $426 · 2023: $169 · 2024: $562 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,529.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $609.27 | 2024-2025 | |
| Organogenesis INC. | $485.87 | 2023-2025 | Puraply Wound Matrix, Nushield, Cygnus Matrix |
| Abbvie INC. | $154.66 | 2022-2025 | |
| Novo Nordisk INC | $129.04 | 2021-2023 | |
| Smith+Nephew, INC. | $113.92 | 2023-2025 | Collagenase Santyl, Renasys Go V2 Home, Grafix Pl |
| Biohaven Pharmaceutical Holding Company LTD. | $109.95 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $81.50 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $69.22 | 2025 | Vibativ |
| Kerecis Limited | $54.65 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $38.43 | 2022-2023 | |
| Sunovion Pharmaceuticals INC. | $28.34 | 2022 | |
| Urgo Medical North America, LLC | $23.24 | 2025 | Urgoclean Ag |
| Ultragenyx Pharmaceutical INC. | $22.12 | 2022 | |
| Amgen INC. | $17.45 | 2022 | |
| Molnlycke Health Care US, LLC | $16.84 | 2023 | Exufiber, Mextra Superabsorbant, Exufiber Ag+ |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $13.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.